@article{TAU23220,
author = {Archana Agarwal and Guru Sonpavde},
title = {A new subtyping model for residual invasive disease after cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {Muscle invasive bladder cancer (MIBC) is an aggressive malignancy and half of the patients develop metastatic disease within 2 years, which is generally incurable and leads to early mortality (1). Based on prospective randomized trials, MIBC is treated with cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) (2-4).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/23220}
}